share_log

HC Wainwright & Co. Reiterates Buy on Anebulo Pharmaceuticals, Maintains $6 Price Target

HC Wainwright & Co. Reiterates Buy on Anebulo Pharmaceuticals, Maintains $6 Price Target

HC Wainwright & Co.重申買入Anebulo Pharmicals,維持6美元的目標股價
Benzinga ·  2023/09/25 06:10

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy and maintains $6 price target.

HC Wainwright&Co.分析師Raghuram Selvaraju重申安尼爾製藥(納斯達克:ANEB)買入,並維持6美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論